Atopic Dermatitis News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Key driver of atopic dermatitis discovered: Finding provides a novel ... - Science Daily



Science Daily
 
Key driver of atopic dermatitis discovered: Finding provides a novel ... 
Science Daily
Severe eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that is driven by an allergic reaction. In a new study, researchers reveal an important player that promotes skin inflammation in atopic dermatitis and the ...

and more » 


Key Driver of Atopic Dermatitis Discovered - Scicasts (press release) (blog)



Scicasts (press release) (blog)
 
Key Driver of Atopic Dermatitis Discovered 
Scicasts (press release) (blog)
La Jolla, CA (Scicasts) ? Severe eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that is driven by an allergic reaction. In their latest study, researchers at La Jolla Institute reveal an important player that ...

and more » 


FDA Grants Upadacitinib Breakthrough Therapy for Atopic Dermatitis - Specialty Pharmacy Times



FDA Grants Upadacitinib Breakthrough Therapy for Atopic Dermatitis 
Specialty Pharmacy Times
AbbVie today announced that the FDA granted breakthrough therapy designation to upadacitinib for adults with moderate-to-severe atopic dermatitis, according to a press release. Upadacitinib is an investigational JAK1-selective inhibitor that ...
AbbVie (ABBV) Says Upadacitinib Granted Breakthrough Therapy Designation FDA for Atopic Dermatitis StreetInsider.com
AbbVie's Upadacitinib Granted Breakthrough Therapy by FDA MD Magazine

all 3 news articles » 


LJI study reveals key player that promotes skin inflammation in atopic dermatitis - Brinkwire (press release)



LJI study reveals key player that promotes skin inflammation in atopic dermatitis 
Brinkwire (press release)
Severe eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that is driven by an allergic reaction. In their latest study, researchers at La Jolla Institute reveal an important player that promotes skin inflammation in ...

 


How to Prevent and Treat Dry Winter Skin - ConsumerReports.org



How to Prevent and Treat Dry Winter Skin 
ConsumerReports.org
Inflammatory skin conditions such as atopic dermatitis and psoriasis and an inherited type of dry skin called ichthyosis typically require prescription medication to treat, Lipner says. Fungal infections can also look like dry skin, she explains, so if ...

 


New Atopic Dermatitis Yardstick provides practical guidance and management insights - EurekAlert (press release)



New Atopic Dermatitis Yardstick provides practical guidance and management insights 
EurekAlert (press release)
ARLINGTON HEIGHTS, IL (January 4, 2018) - Patients with atopic dermatitis (AD) - also known as eczema - often face a tough, uphill battle for treatment. Symptoms include severe itching, scaly rashes, extreme dry skin and inflammation. Those who suffer ...

and more » 


FDA Grants AbbVie's Upadacitinib Breakthrough Therapy Designation for Atopic Dermatitis - Drug Discovery & Development



Drug Discovery & Development
 
FDA Grants AbbVie's Upadacitinib Breakthrough Therapy Designation for Atopic Dermatitis 
Drug Discovery & Development
AbbVie announced the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for the investigational, once-daily oral JAK1-selective inhibitor upadacitinib (ABT-494) in adult patients with moderate to severe atopic dermatitis ...
Upadacitinib receives breakthrough therapy designation for atopic dermatitis European Pharmaceutical Review
BRIEF?Breakthrough status for upadacitinib in atopic dermatitis The Pharma Letter
AbbVie's JAK1 Inhibitor Granted FDA's Breakthrough Therapy GuruFocus.com

all 5 news articles » 


Study Quantifies Burden of Atopic Dermatitis on Patients - AJMC.com Managed Markets Network



AJMC.com Managed Markets Network
 
Study Quantifies Burden of Atopic Dermatitis on Patients 
AJMC.com Managed Markets Network
Patients with atopic dermatitis (AD) have a significantly greater risk for additional atopic diseases, as well as significantly greater healthcare resource utilization and total cost compared with adults without AD. The burden of AD was generally ...

 


Understanding AbbVie's Positive Upadacitinib Data for Atopic Dermatitis - Market Realist



Market Realist
 
Understanding AbbVie's Positive Upadacitinib Data for Atopic Dermatitis 
Market Realist
On September 7, 2017, AbbVie (ABBV) posted positive results from a phase-2 clinical trial that studied the efficacy of its investigational therapy, Upadacitinib, in adult patients suffering from moderate to severe atopic dermatitis (or AD) who didn't ...

 


FDA APPROVAL OF DUPIXENT (DUPILUMAB) to be a major growth ... - Coherent News (press release) (blog)



Coherent News (press release) (blog)
 
FDA APPROVAL OF DUPIXENT (DUPILUMAB) to be a major growth ... 
Coherent News (press release) (blog)
Atopic dermatitis, also known as eczema, is a condition in which skin becomes dry, itchy, and inflamed, which leads to redness, swelling, scaling, and crusting. Atopic dermatitis is commonly found in children under one year. The exact cause of atopic ...

and more »